{
  "docId": "019de072-076d-72ac-ab8c-eccaf913414b",
  "docSlug": "8b7c2d189783c7b26f6b80a3e9e1c0e2",
  "documentTitle": "NNIT | Results Presentation Deck | 26 slides",
  "authorId": "nnit",
  "authorName": "NNIT",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 20,
  "pageCount": 26,
  "prevPage": 19,
  "nextPage": 21,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 18,
  "notes": "The chart compares Q1-21 through Q4-21 against Q1-22, highlighting segment-specific growth/decline.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-076d-72ac-ab8c-eccaf913414b/20",
  "deckHref": "/decks/019de072-076d-72ac-ab8c-eccaf913414b",
  "deckJsonHref": "/decks/019de072-076d-72ac-ab8c-eccaf913414b.json",
  "deckAnchorHref": "/decks/019de072-076d-72ac-ab8c-eccaf913414b#slide-20",
  "components": [
    {
      "bbox": {
        "h": 0.35,
        "w": 0.38,
        "x": 0.12,
        "y": 0.44
      },
      "kind": "chart",
      "text": "Stacked bar chart showing backlog values by segment (Life Sciences, Novo Nordisk, Private & Public) from Q1-21 to Q1-22.",
      "attrs": null,
      "subkind": "bar-stacked",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3da56029-afec-4404-b658-1d6317884738",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.4,
        "x": 0.12,
        "y": 0.85
      },
      "kind": "legend",
      "text": "Life Sciences (excl. NNG) | Novo Nordisk Group | Private & Public",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "57208d00-bd52-4a63-9c5c-5c95d3fbe4c9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.35,
        "x": 0.6,
        "y": 0.44
      },
      "kind": "list",
      "text": "At the beginning of Q4 2022, NNIT's order entry backlog for 2022 amounted to DKK 2,017 million, up 0.9% from last year. Life Sciences (excl. NNG) customers increased by 14.2%. Novo Nordisk Group decreased by 6.2%. Private & Public decreased by 2.2%.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "358d0caf-f1f2-4e26-a861-f6ed0316cbbe",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.35,
        "x": 0.6,
        "y": 0.64
      },
      "kind": "paragraph",
      "text": "The high growth forecast within NNIT's project business has a relative low backlog visibility. Therefore, the backlog for the current year should not be used in isolation as a proxy for the upcoming year.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1bee4b60-22ba-4675-b163-63aa41538007",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.45,
        "x": 0.068,
        "y": 0.045
      },
      "kind": "title",
      "text": "Backlog development, current year",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0639a719-d27d-477d-89ed-378b87338393",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Chart Selection Guide",
      "slug": "chart-selection-guide",
      "agent": "Designer",
      "layer": "slide",
      "matchId": "5b729219-2e3c-48d6-91f2-08da09f66261",
      "evidence": "chart/bar-stacked: Stacked bar chart showing backlog values by segment (Life Sciences, Novo Nordisk, Private & Public) from Q1-21 to Q1-22.",
      "confidence": 0.7
    },
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "2f424fba-8c06-4ff0-8a48-5d86f68507d3",
      "evidence": "list/bullet: At the beginning of Q4 2022, NNIT's order entry backlog for 2022 amounted to DKK 2,017 million, up 0.9% from last year.",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}